Financial Daily from THE HINDU group of publications
Saturday, Oct 30, 2004
Financial Daily from THE HINDU group of publications Saturday, Oct 30, 2004 |
||
|
|
||
|
Corporate
-
Announcements Ranbaxy approaches FDA for anti-AIDS drug Our Bureau
New Delhi , Oct. 29 RANBAXY Laboratories Ltd has filed its first abbreviated new drug approval (ANDA) with the US Food & Drug Administration (FDA) for zidovudine tablets an anti-retroviral drug used for the treatment of AIDS. This is the first of a series of anti-retroviral (ARV) ANDA filings by the company that are anticipated in the near term that will be supportive of the US President's Emergency Plan for AIDS Relief (PEPFAR) initiative. According to an official statement, the company will generate and provide appropriate scientific data supporting the efficacy of zidovudine tablets in order to allow the FDA to technically review the formulation and grant final approval. With FDA approval, the formulation can then be employed to manage patients afflicted with AIDS in PEPFAR identified countries, when mutually acceptable procurement terms are agreed upon. "Ranbaxy's plan is to provide single entity products and fixed dose combination products in the future for FDA approval that can then be employed by PEPFAR to meet the clinical needs of patients," it said.
More Stories on : Announcements | Pharmaceuticals
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2004, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|